Is Tesamorelin legal in Delaware?
status · no specific restrictions
FDA-approved GHRH analogue (Egrifta) for HIV lipodystrophy; WADA S2.2 explicitly prohibited; 'research-grade' tesamorelin from retail vendors is unapproved diversion. No state-level peptide restrictions beyond federal law in Delaware.
category: fda approved · last verified May 13, 2026
§ 01
Quick answer
FDA-approved GHRH analogue (Egrifta) for HIV lipodystrophy; WADA S2.2 explicitly prohibited; 'research-grade' tesamorelin from retail vendors is unapproved diversion. No state-level peptide restrictions beyond federal law in Delaware.
§ 02
Full status breakdown
Federal status
FDA approval
approved as drug · brand: Egrifta, Egrifta SV, Egrifta WR · NDA 022505 · approved Nov 10, 2010
Indications: Reduction of excess abdominal fat in HIV lipodystrophy
DEA scheduling
not scheduled
503A compounding
Bulks list: not on list
Do-not-compound list: not on list
Component of an approved drug; bulks pathway generally unavailable. Now transitioned to 'deemed BLA' status under March 23, 2020 framework which further restricts bulk-substance compounding.
FDA Warning Letters
none on record for this compound
Shortage status
not currently on shortage list
Sale framing
Research-use-only posture: Brand Egrifta is Rx-only; 'research-grade tesamorelin' from peptide retailers is unapproved and FDA's RUO posture rejection applies.
Personal possession: Lawfully obtained Rx Egrifta is lawful to possess. Unapproved compounded/research-source tesamorelin is at enforcement risk on the seller side.
Delaware — state-specific
Sport-body status
WADA 2026
on prohibited list · class S2.2 · both
Explicitly named under S2.2 (Growth Hormone-Releasing Factors). Also referenced in WADA GHRF guidance.
USADA
banned
NCAA
banned
What we couldn’t verify
§ 03
Also known as
Tesamorelin is also marketed or referenced under the following names (vendor pseudonyms, brand names, chemical identifiers):
EgriftaEgrifta SVEgrifta WRTH9507GHRH analogue
§ 04
Disclaimer
§ 05
Related
- Back to peptide legality lookup — pick a different compound or state
- Tesamorelin research guide — mechanism, dosing math, vendor audits, COA data
- Peptide pricing index — what each compound costs per mg across audited vendors
- Janoshik COA verifier — a separate question from legality: does the COA the vendor cites actually exist?
the roundup · monthly
Receipts in your inbox. Once a month.
New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.
14,200 subscribers· 0 sponsored items· 11 issues since launch